EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level  |
|---|
   1.4.4.2 | Aneurysm |
8811701 |
Endovascular occlusion of intracranial aneurysms of the posterior circulation: comparison of balloons, free coils and detachable coils in 38 patients. |
diagnostic usage
therapeutic application
unassigned |
2
1
0 |
| 1.4.4.2 | Aneurysm |
8875460 |
Pulsation-pressure relationship in experimental aneurysms: observation of aneurysmal hysteresis. |
diagnostic usage
therapeutic application
unassigned |
3
1
0 |
| 1.4.4.2 | Aneurysm |
9011992 |
[Embolization of cerebral aneurysms. A new therapeutic possibility] |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 1.4.4.2 | Aneurysm |
9254079 |
Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. |
diagnostic usage
unassigned |
2
0 |
| 1.4.4.2 | Aneurysm |
9384409 |
Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery. Case report and review of the literature. |
unassigned |
0 |
| 1.4.4.2 | Aneurysm |
9432175 |
Guglielmi detachable coil embolization for unruptured aneurysms in nonsurgical candidates: a cost-effectiveness exploration. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
1
2
0 |
| 1.4.4.2 | Aneurysm |
9446479 |
[The endovascular treatment of cerebral arteriovenous aneurysms and malformations] |
therapeutic application
unassigned |
3
0 |
| 1.4.4.2 | Aneurysm |
9472893 |
Randomized comparison of Guglielmi detachable coils and cellulose acetate polymer for treatment of aneurysms in dogs. |
causal interaction
therapeutic application
unassigned |
4
3
0 |
| 1.4.4.2 | Aneurysm |
9613510 |
Endovascular treatment of pseudoaneurysms with electrolytically detachable coils. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 1.4.4.2 | Aneurysm |
9647176 |
Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils: results of the Food and Drug Administration multicenter clinical trial. |
therapeutic application
unassigned |
4
0 |
